Hepatocellular carcinoma: Comparison of two different periods at the same center

Montalto, 2002, Epidemiology, risk factors and natural history of hepatocellular carcinoma, Ann N Y Acad Sci, 963, 13, 10.1111/j.1749-6632.2002.tb04090.x Simonetti, 1991, Hepatocellular carcinoma: a worldwide problem and the major risk factors, Dig Dis Sci, 36, 862, 10.1007/BF01297149 Velazquez, 2003, Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis, Hepatology, 37, 520, 10.1053/jhep.2003.50093 El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 Shimada, 2002, Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis, J Hepatol, 37, 154, 10.1016/S0168-8278(02)00099-5 Adams, 2005, The natural history of non-alcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014 Marrero, 2002, NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States, Hepatology, 36, 1349, 10.1053/jhep.2002.36939 Carroccio, 1999, Aspetti clinici ed eziologici dell'epatocarcinoma in Sicilia, Ann It Med Int, 14, 233 Bruix, 2005, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma, Hepatology, 42, 1208, 10.1002/hep.20933 2000, A new prognostic system for patient with cirrhosis and hepatocellular carcinoma, Hepatology, 31, 840, 10.1053/he.2000.5628 Huo, T.I., Hsia, C.Y., Huang, Y.H., Lin, H.C., Lee, P.C., Lui, W.Y. et al. Selecting a Short-term Prognostic Model for Hepatocellular Carcinoma: Comparison Between the Model for End-stage Liver Disease (MELD), MELD-sodium, and Five Cancer Staging Systems. J Clin Gastroenterol 2009; Epub ahead of print. Mar 3. Soresi, 1998, Ultrasound detection of abdominal lymphoadenomegaly in subjects with hepatitis C virus infection and persistenly normal transaminases. A predictive index of liver histology severity, J Hepatol, 22, 544, 10.1016/S0168-8278(98)80276-6 Montalto, 1998, Clinical evaluation of pancreatitis-associated proteina s a marker of hepatocellular carcinoma: comparison with alpha-fetoprotein, Oncology, 55, 421, 10.1159/000011889 Bosch, 2005, Epidemiology of hepatocellular carcinoma, Dig Liv Dis, 9, 191 De Bac, 1994, Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter talian study, Hepatology, 20, 1125, 10.1002/hep.1840200519 Stroffolini, 1998, Characteristic of hepatocellular carcinoma in Italy, J Hepatol, 29, 944, 10.1016/S0168-8278(98)80122-0 Sagnelli, 2005, The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence of 9, 997 cases, J Med Virol, 75, 522, 10.1002/jmv.20313 Montalto, 1995, Frequenza di positività per anti-HCV in una popolazione di epatopatici siciliani, Ann It Med Int, 10, 89 Trevisani, 2002, Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience), Am J Gastroenterol, 97, 734, 10.1111/j.1572-0241.2002.05557.x Trevisani, 1995, Etiologic factors and clinical presentation of hepatocellular carcinoma, Cancer, 75, 2220, 10.1002/1097-0142(19950501)75:9<2220::AID-CNCR2820750906>3.0.CO;2-4 Borzio, 2007, (Gruppo epatologico Lombardo) Epidemiology and outcome of hepatocellular carcinoma in Lombardy, Dig Liv Dis, 39, 1011, 10.1016/j.dld.2007.06.018 Okuda, 1989, Hepatocellular cacinoma without cirrhosis in Japanese patients, Gastroenterology, 97, 140, 10.1016/0016-5085(89)91427-3 Chiesa, 2000, Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis, Cancer Epidemiol Biomarkers Prev, 9, 213